Researchers at Oxford University are working with great care, and due haste, in developing a new vaccine for coronavirus. If proven effective, a safe coronavirus vaccine could provide an exit strategy for the pandemic and save lives. While we understand the interest, we ask that the media do not continue to contact researchers while this critical work is underway so that they can focus on these efforts.
Update: Oxford Covid-19 trial vaccinations resume in South Africa (Thurs 17 Sept)
Update: Brazilian trial of Oxford vaccine resumes (Mon 14th Sept)
Update: University of Oxford resumes vaccine trial (Sat 12th Sept)
Update: Data under review for Phase II/III study (Wed 9th Sept)
Blog: Explained - Safety and Immunogenicity of the ChAdOx1 nCoV-19 Vaccine (Mon 20th July)
Announcement: New Study Reveals Coronavirus Vaccine Produces Strong Immune Response (Mon 20th July)
Announcement: Trial of Oxford COVID-19 vaccine starts in Brazil (Sat 27th June)
Announcement: Trial of Oxford COVID-19 vaccine starts in South Africa (Tues 23rd June)
Announcement: Brazilian Health Regulatory Agency approves trial of Oxford COVID-19 Vaccine (Wed 3rd June)
Q&A: UN Talk – Prof. Sarah Gilbert (Tues 2nd June)
Blog: The Phase II/III Trial Explained (Fri 22nd May)
Announcement: Landmark partnership announced for development of COVID-19 vaccine (Thurs 30th April 2020)
Update: News about trial progress (Sun 26th April 2020)
Statement: Future Deliberations - Kenya Medical Research Institute (KEMRI) (Fri 24th April 2020)
Blog: The Phase I Clinical Trial Explained. (Thurs 23rd April 2020)
Briefing: Statement following the UK Government announcement. (Tues 21st April 2020)
Q&A: An interview with Prof. Sarah Gilbert (Sun 19th April 2020)
Blog: How long will it take to get the Oxford vaccine to deployment? (Thurs 2nd April 2020)
Press Release: Oxford COVID-19 vaccine programme opens for clinical trial recruitment (Friday 27th March 2020)
If you would like to receive updates about the trial, please sign up to our mailing list. This list is for press contacts only.
Sign up to receive updates
The Medical Sciences Division Data Privacy Notice describes how we collect and use your personal data submitted to us online, by email, on paper or face-to-face, in accordance with the General Data Protection Regulation (GDPR) and associated data protection legislation.
This information is for Press enquiries only. If you would like to find out more about participating in the trial, please click here.
Please read the press releases above before contacting us as your question may be answered there. For further enquiries, please contact the University of Oxford Press Office. We will try to respond to your message (if appropriate) as soon as we can, however we are unable to respond to all messages and responses may be delayed due to the nature of the current situation.